The Lancet Respiratory Medicine in conversation with
Podcast autorstwa The Lancet Group
156 Odcinki
-
Inhaled budesonide in the treatment of early COVID-19
Opublikowany: 15.04.2021 -
Tocilizumab and COVID-19
Opublikowany: 5.03.2021 -
Interferon treatment and COVID-19
Opublikowany: 6.02.2021 -
Evaluating deterioration in patients with acute COVID-19
Opublikowany: 12.01.2021 -
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Opublikowany: 5.01.2021 -
COVID-19 and severe influenza
Opublikowany: 18.12.2020 -
The second wave and homeless populations
Opublikowany: 11.11.2020 -
Corticosteroids, COPD, asthma and COVID-19
Opublikowany: 25.09.2020 -
Novel strategies to drive down the global burden of asthma
Opublikowany: 8.09.2020 -
The pathology of suspected EVALI
Opublikowany: 5.08.2020 -
Wheezing illness and RSV-LRTI
Opublikowany: 17.07.2020 -
Antibiotic use in infancy and asthma incidence
Opublikowany: 16.03.2020 -
Guidance on the development of prediction models for critical care
Opublikowany: 12.03.2020 -
Potential exacerbations in patients with COPD
Opublikowany: 3.03.2020 -
CPAP and mild obstructive sleep apnea
Opublikowany: 28.11.2019 -
An algorithm for EVALI
Opublikowany: 8.11.2019 -
Lung transplants from Hepatitis C viremic donors
Opublikowany: 5.10.2019 -
Looking to the future of cystic fibrosis care
Opublikowany: 29.09.2019 -
Pamrevlumab and idiopathic pulmonary fibrosis
Opublikowany: 27.09.2019 -
Nicotine patches, e-cigarettes, and smoking cessation
Opublikowany: 10.09.2019
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
